Table 1. Cytotoxicity of Lipofectamine/dendrimer and short RNA complex reported in some other studies compared to ours .
| Cell line | Volume in 500 μL | Viability (%) compared to blank | Ref. |
| T47D | 0.4 μL Lipofectamine | 98.5 | This study |
| 0.75 μL Lipofectamine | 88.5 | ||
| PAMAM G5 N/P = 10 | 92.5 | ||
| PAMAMG5 N/P = 20 | 88.5 | ||
| PAMAMG5 N/P = 40 | 74.5 | ||
| MCF-10A | 0.4 μL Lipofectamine | 99 | |
| 0.75 μL Lipofectamine | 99 | ||
| T47D | PAMAM G2, G3, G4 and G5 | Toxic at the higher generations | 28 |
| HEK293 | 1.5 μL Lipofectamine | No apparent toxic effect | 15 |
| SW480 | 2 μL Lipofectamine | Without significant toxicity | 31 |
| Huh-7 | 2 μL Lipofectamine | 75.34 | 16 |
| HEK2 | 87.29 | ||
| MCF-7 | 92.49 | ||
| U87MG | 80 |